State Street’s Science 37 Holdings, Inc. Common Stock SNCE Stock Holding History

State Street’s Portfolio SNCE Stock Details SNCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-10,144	Closed	-$54.2K	–	4437
2023 Q4	$54.2K	Buy	10,144 +280	+3%	+$1.73K	﹤0.01%	4181
2023 Q3	$78.9K	Hold	9,864	–	–	﹤0.01%	4168
2023 Q2	$41.9K	Sell	9,864 -40,237	-80%	-$228K	﹤0.01%	4462
2023 Q1	$282K	Buy	50,101 +62	+0.1%	+$471	﹤0.01%	3947
2022 Q4	$416K	Sell	50,039 -1,386	-3%	-$27.1K	﹤0.01%	3832
2022 Q3	$1.66M	Buy	51,425 +4,089	+9%	+$152K	﹤0.01%	3464
2022 Q2	$1.9M	Buy	47,336 +38,602	+442%	+$2.82M	﹤0.01%	3498
2022 Q1	$935K	Buy	8,734 +7,189	+465%	+$1.13M	﹤0.01%	3834
2021 Q4	$385K	Buy	+1,545	New	+$343K	﹤0.01%	4104

State Street's SNCE Position: Q1 2024 in Review

State Street sold out of Science 37 Holdings, Inc. Common Stock (SNCE) in Q1 2024, closing a stake of 10,144 shares — an estimated $54.2K sold.

State Street first reported a position in SNCE in Q4 2021 and held it in 9 quarters. The position peaked at $1.9M in Q2 2022. 0 funds tracked by Wall St. Rank hold SNCE as of Q1 2024.

State Street reported no remaining Science 37 Holdings, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
State Street sold 10,144 Science 37 Holdings, Inc. Common Stock shares in Q1 2024, an estimated $54.2K.
State Street first reported a position in Science 37 Holdings, Inc. Common Stock in Q4 2021 and held it in 9 quarters.
State Street's Science 37 Holdings, Inc. Common Stock position peaked at $1.9M in Q2 2022.
0 funds tracked by Wall St. Rank held Science 37 Holdings, Inc. Common Stock as of Q1 2024.

Based on State Street's 13F filing for Q1 2024, filed 15 May 2024.